Researchers say an immunotherapy drug could be a game
changer for patients suffering with a relapse of head
and neck cancer.
A New England Journal of Medicine study found more
than double the number of patients were alive after
taking the drug "nivolumab" (niv-ole-yoo-mab) for
one year compared to patients treated with chemotherapy.
Patients also reported fewer serious side effects.
The cost of treating breast cancer with chemotherapy
varies widely even when the treatments have similar
That's according to new research published in the
The study also found patients are often left with
significant out of pocket costs.
And the number of kids around the world with health
problems linked to obesity will skyrocket in the coming
Scientists estimate as many as 12 million children
will have prediabetes and 4 million will have type
2 diabetes in 2025.
Those are the day's top health stories. Brook Silva
Braga, CBS News, New York.